Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emily A Rudmann"'
Autor:
Saima Ahmed, Patrick van Zalm, Emily A. Rudmann, Michael Leone, Kiana Keller, John A. Branda, Judith Steen, Shibani S. Mukerji, Hanno Steen
Publikováno v:
Viruses, Vol 14, Iss 12, p 2757 (2022)
Herpesviruses have complex mechanisms enabling infection of the human CNS and evasion of the immune system, allowing for indefinite latency in the host. Herpesvirus infections can cause severe complications of the central nervous system (CNS). Here,
Externí odkaz:
https://doaj.org/article/9854b48c7f3d46579357a022b2699a6b
Autor:
Erica Normandin, Navid Valizadeh, Emily A Rudmann, Rockib Uddin, Sabrina T Dobbins, Bronwyn L MacInnis, Robert F Padera, Katherine J Siddle, Jacob E Lemieux, Pardis C Sabeti, Shibani S Mukerji, Isaac H Solomon
Publikováno v:
Journal of Neuropathology & Experimental Neurology. 82:283-295
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continually evolving resulting in variants with increased transmissibility, more severe disease, reduced effectiveness of treatments or vaccines, or diagnostic detection failure. The SAR
Autor:
Douglas R. Wilcox, Emily A. Rudmann, Elissa Ye, Ayush Noori, Colin Magdamo, Aayushee Jain, Haitham Alabsi, Brody Foy, Virginia A. Triant, Gregory K. Robbins, M. Brandon Westover, Sudeshna Das, Shibani S. Mukerji
Publikováno v:
AIDS.
Autor:
Eric A Meyerowitz, Shibani S Mukerji, G Kyle Harrold, Rachel M Erdil, Steven T Chen, Emily A Rudmann, Athe Tsibris, Nagagopal Venna, Gregory K Robbins
Publikováno v:
Clinical Infectious Diseases.
Background Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neurological condition characterized by progressive myelopathic symptoms including spasticity, pain, weakness, and urinary
Autor:
Shibani S Mukerji, Douglas R Wilcox, Emily A Rudmann, Elissa Ye, Ayush Noori, Colin Magdamo, Haitham Alabsi, Virginia A Triant, Gregory Robbins, M Brandon Westover, Sudeshna Das
Publikováno v:
Open Forum Infectious Diseases. 9
Background Despite higher prevalence of cognitive disorders in people with human immunodeficiency virus (PWH) and dementia being a risk factor for COVID-19 mortality, the association between dementia and adverse outcomes in PWH with COVID-19 has not